• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎-间质性肺疾病和家族性肺纤维化的共享遗传易感性。

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis.

机构信息

APHP, Hôpital Bichat, Service de Rhumatologie, DHU FIRE, Paris, France.

Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

出版信息

Eur Respir J. 2017 May 11;49(5). doi: 10.1183/13993003.02314-2016. Print 2017 May.

DOI:10.1183/13993003.02314-2016
PMID:28495692
Abstract

Despite its high prevalence and mortality, little is known about the pathogenesis of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Given that familial pulmonary fibrosis (FPF) and RA-ILD frequently share the usual pattern of interstitial pneumonia and common environmental risk factors, we hypothesised that the two diseases might share additional risk factors, including FPF-linked genes. Our aim was to identify coding mutations of FPF-risk genes associated with RA-ILD.We used whole exome sequencing (WES), followed by restricted analysis of a discrete number of FPF-linked genes and performed a burden test to assess the excess number of mutations in RA-ILD patients compared to controls.Among the 101 RA-ILD patients included, 12 (11.9%) had 13 WES-identified heterozygous mutations in the , , or coding regions The burden test, based on 81 RA-ILD patients and 1010 controls of European ancestry, revealed an excess of , , or mutations in RA-ILD patients (OR 3.17, 95% CI 1.53-6.12; p=9.45×10). Telomeres were shorter in RA-ILD patients with a , or mutation than in controls (p=2.87×10).Our results support the contribution of FPF-linked genes to RA-ILD susceptibility.

摘要

尽管类风湿关节炎相关间质性肺病(RA-ILD)的患病率和死亡率很高,但人们对其发病机制知之甚少。鉴于家族性肺纤维化(FPF)和 RA-ILD 常共享间质性肺炎的常见模式和常见环境危险因素,我们假设这两种疾病可能具有其他共同的危险因素,包括与 FPF 相关的基因。我们的目的是确定与 RA-ILD 相关的 FPF 风险基因的编码突变。

我们使用外显子组测序(WES),然后对离散数量的 FPF 相关基因进行受限分析,并进行负担测试,以评估与对照组相比,RA-ILD 患者的突变数量是否过多。

在纳入的 101 例 RA-ILD 患者中,有 12 例(11.9%)在 、 、 或 编码区域中发现了 13 个 WES 鉴定的杂合突变。基于 81 例 RA-ILD 患者和 1010 例欧洲血统对照,负担测试显示 RA-ILD 患者中 、 、 或 突变过多(OR 3.17,95%CI 1.53-6.12;p=9.45×10)。与对照组相比,携带 、 或 突变的 RA-ILD 患者的端粒较短(p=2.87×10)。

我们的结果支持 FPF 相关基因对 RA-ILD 易感性的贡献。

相似文献

1
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis.类风湿关节炎-间质性肺疾病和家族性肺纤维化的共享遗传易感性。
Eur Respir J. 2017 May 11;49(5). doi: 10.1183/13993003.02314-2016. Print 2017 May.
2
Regulator of telomere length 1 () mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes.端粒长度调节因子 1()突变与异质性的肺内和肺外表型相关。
Eur Respir J. 2019 Feb 7;53(2). doi: 10.1183/13993003.00508-2018. Print 2019 Feb.
3
The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China.中国类风湿关节炎相关间质性肺病患者 MUC5B 突变与临床结局的相关性:一项回顾性探索性研究。
Med Sci Monit. 2020 Mar 6;26:e920137. doi: 10.12659/MSM.920137.
4
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.MUC5B 启动子变异与伴有间质性肺病的类风湿关节炎。
N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.
5
Recent advances in rheumatoid arthritis-associated interstitial lung disease.类风湿关节炎相关间质性肺疾病的最新进展。
Curr Opin Pulm Med. 2020 Sep;26(5):477-486. doi: 10.1097/MCP.0000000000000710.
6
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis.杂合性 RTEL1 突变与家族性肺纤维化有关。
Eur Respir J. 2015 Aug;46(2):474-85. doi: 10.1183/09031936.00040115. Epub 2015 May 28.
7
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.将基因组学纳入特发性肺纤维化的管理中。
Chest. 2019 May;155(5):1026-1040. doi: 10.1016/j.chest.2018.12.011. Epub 2019 Jan 17.
8
Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).纤维化性间质性肺炎可预测类风湿关节炎相关间质性肺病(RA-ILD)患者的生存情况。
Respir Med. 2013 Aug;107(8):1247-52. doi: 10.1016/j.rmed.2013.05.002. Epub 2013 Jun 19.
9
Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease.类风湿关节炎相关间质性肺病的遗传、社会和环境危险因素。
Semin Arthritis Rheum. 2022 Dec;57:152098. doi: 10.1016/j.semarthrit.2022.152098. Epub 2022 Sep 17.
10
SLAMF1 as a novel molecule mediating the causal association between rheumatoid arthritis and interstitial lung disease: A Mendelian randomization study combined with transcriptomics and in vivo validation.SLAMF1 作为一种新型分子介导类风湿关节炎与间质性肺病之间的因果关联:一项结合转录组学和体内验证的孟德尔随机化研究。
Int Immunopharmacol. 2024 Dec 5;142(Pt A):113082. doi: 10.1016/j.intimp.2024.113082. Epub 2024 Sep 10.

引用本文的文献

1
A comparative analysis of clinical phenotypes and outcomes in childhood interstitial lung disease due to surfactant dysfunction disorders: focusing on mutations in SFTPC, ABCA3, and NKX2-1 genes.表面活性剂功能障碍性疾病所致儿童间质性肺疾病的临床表型与结局的比较分析:聚焦于SFTPC、ABCA3和NKX2-1基因的突变
Ital J Pediatr. 2025 Aug 27;51(1):265. doi: 10.1186/s13052-025-02110-8.
2
Assessing the promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease.在一大群系统性硬化症相关间质性肺病患者中评估启动子变异体。
RMD Open. 2025 Aug 12;11(3):e005754. doi: 10.1136/rmdopen-2025-005754.
3
Treating connective tissue disease-associated interstitial lung disease - think outside the box: a perspective.
治疗结缔组织病相关间质性肺病——跳出框框思考:一种观点
Eur Respir Rev. 2025 Jul 23;34(177). doi: 10.1183/16000617.0046-2025. Print 2025 Jul.
4
Treatment Strategies for Acute Exacerbation of Interstitial Lung Disease Associated with Systemic Autoimmune Rheumatic Diseases in Chinese Patients: A Scoping Review.中国患者系统性自身免疫性风湿疾病相关间质性肺疾病急性加重的治疗策略:一项范围综述
Rheumatol Ther. 2025 Jul 21. doi: 10.1007/s40744-025-00785-3.
5
Telomere Shortening in Interstitial Lung Disease: Challenges and Promises.间质性肺疾病中的端粒缩短:挑战与前景
Clin Respir J. 2025 Jul;19(7):e70103. doi: 10.1111/crj.70103.
6
Predictive Biomarkers and Novel Treatments for the Progressive Fibrosing Phenotype in Interstitial Lung Disease Associated with Connective Tissue Disease.与结缔组织病相关的间质性肺病中进行性纤维化表型的预测生物标志物和新疗法
Biomedicines. 2025 Jun 13;13(6):1463. doi: 10.3390/biomedicines13061463.
7
Germline PARN Variants in Telomere Biology Disorders and Challenges in Variant Curation.端粒生物学障碍中的种系PARN变异及变异整理面临的挑战
Mol Genet Genomic Med. 2025 Jun;13(6):e70107. doi: 10.1002/mgg3.70107.
8
Insights into interstitial lung disease pathogenesis.间质性肺疾病发病机制的见解。
Breathe (Sheff). 2025 May 13;21(2):240261. doi: 10.1183/20734735.0261-2024. eCollection 2025 Apr.
9
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation.特发性肺纤维化患者的罕见变异与生存情况:一项多中心观察性队列研究及独立验证分析
Lancet Respir Med. 2025 Jun;13(6):495-504. doi: 10.1016/S2213-2600(25)00045-1. Epub 2025 Apr 28.
10
DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case-control study.反映肺纤维化途径的类风湿关节炎相关间质性肺疾病的DNA甲基化组生物标志物:一项探索性病例对照研究
Sci Rep. 2025 Apr 29;15(1):15123. doi: 10.1038/s41598-025-99755-6.